Cultzyme

Cultzyme

Private
Donostia-San SebastiánHealthcare & Life Scienceshttps://cultzyme.com/

Last Round

Accelerator

Sep 30, 2024

Total Funding Raised

$620,000

Company Overview

Cultzyme is a biotechnology company that produces and supplies high-value proteins for the food industry through a cost-effective and sustainable precision fermentation platform.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing, Drug Discovery, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

intelligent bioreactorbioprocessing platformprecision fermentationautonomous bioprocessingbiotech automationcell culturebiomanufacturingAI for biotechsynthetic biologyalternative proteinsbiomaterialsbiotechnology equipmentdrug development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cultzyme Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cultzyme Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 30, 2024
SeedMay 8, 2022

Key People

Founding team and executive leadership

Juan Manuel Garzón Vela

CEO, Founder

Founding Team

Rubén P.

Chief Technology Officer

Executive Team

Sandra G.

CFO

Executive Team

Cultzyme Investors

Notable investors and investment history

InvestorRounds
Nucleus CapitalSeed
DeepTek Gipuzkoa FundazioaAccelerator
BIC GipuzkoaAccelerator
Pascual InnoventuresAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2025

    Grew 63% QoQ, from 8 to 13 employees.

  • Jun 6, 2025

    Grew 50% QoQ from 8 to 12 employees.

Cultzyme Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cultzyme Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cultzyme's valuation, stock price, and market status.

Firmographic Details

HeadquartersDonostia-San Sebastián
Employee Range14
Year Founded2021
Last FundingSep 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.